NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 670961 | Null | 0.00126952303154153 | 0.59480687 |
NSC 677624 | Null | 0.00126952303154153 | 0.21287736 |
NSC 682864 | Null | 0.00126952303154153 | 0.13177267 |
NSC 711611 | Null | 0.00126952303154153 | 0.47014476 |
NSC 725191 | 1,6-bis[(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-10-(trifluorometh yl)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexade c-9-en-9-yl]-3-hexene-1,6-diol | 0.00126952303154153 | 0.52478309 |
NSC 736164 | pyrazoline derivative | 0.00126952303154153 | 0.53039409 |
NSC 736914 | Null | 0.00126952303154153 | 0.35010388 |
NSC 763646 | (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole | 0.00126952303154153 | 0.20381587 |
NSC 128571 | Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) | 0.00126952303154154 | 0.46356524 |
NSC 169774 | Bromocriptine methanesulfonate | 0.00126952303154154 | 0.51143741 |